Cargando…
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
The synaptic vesicle glycoprotein SV2A belongs to the major facilitator superfamily (MFS) of transporters and is an integral constituent of synaptic vesicle membranes. SV2A has been demonstrated to be involved in vesicle trafficking and exocytosis, processes crucial for neurotransmission. The anti-s...
Autores principales: | Löscher, Wolfgang, Gillard, Michel, Sands, Zara A., Kaminski, Rafal M., Klitgaard, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078162/ https://www.ncbi.nlm.nih.gov/pubmed/27752944 http://dx.doi.org/10.1007/s40263-016-0384-x |
Ejemplares similares
-
A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
por: Finnema, Sjoerd J., et al.
Publicado: (2019) -
Synaptic Vesicles Dynamics in Neocortical Epilepsy
por: Vannini, Eleonora, et al.
Publicado: (2020) -
Synaptic Vesicle Glycoprotein 2A: Features and Functions
por: Rossi, Rachele, et al.
Publicado: (2022) -
Dogs as a Natural Animal Model of Epilepsy
por: Löscher, Wolfgang
Publicado: (2022) -
Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE)
por: Pazarlar, Burcu A., et al.
Publicado: (2022)